Drug and device manufacturer communications with payors, formulary committees, and similar entities: questions and answers : guidance for industry and review staff Drug and device manufacturer communications with payors, formulary committees, and similar entities: questions and answers : guidance for industry and review staff

Collection: Health Policy and Services Research Series Title(s): Guidance for industry Contributor(s): United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. United States. Food and Drug Administration. Office of the Commissioner, issuing body. Center for Biologics Evaluation and Research (U.S.), issuing body. Center for Devices and Radiological Health (U.S.), issuing body. Center for Drug Evaluation and Research (U.S.), issuing body. Publication: Silver Spring, MD : Center for Drug Evaluation and Research, June 2018 Language(s): English Format: Text Subject(s): Communication Equipment and Supplies -- economics Insurance, Health, Reimbursement -- economics Pharmaceutical Preparations -- economics Truth Disclosure United States United States. Department of Health and Human Services United States. Food and Drug Administration Genre(s): Guideline Technical Report Copyright: The National Library of Medicine believes this item to be in the public domain. (More information) Extent: 1 online resource (1 PDF file (23 pages)). NLM Unique ID: 101734304 (See catalog record) Permanent Link: http://resource.nlm.nih.gov/101734304